- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Automatic Translation feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Evaluation of reticulocyte hemoglobin content, percentage of hypochromic red blood cells, and ratio of serum transferrin receptor level/serum iron level as markers of iron-deficiency erythropoiesis in patients undergoing hemodialysis.
-
- HASEGAWA Midori
- Department of Nephrology, Fujita Health University School of Medicine
-
- KAWAMURA Nahoko
- Showa Hospital
-
- KOIDE Sigehisa
- Showa Hospital
-
- MURASE Masamitsu
- Showa Hospital
-
- ASANO Sinsuke
- Showa Hospital
-
- TOBA Takako
- Showa Hospital
-
- KUSHIMOTO Hiroko
- Department of Nephrology, Fujita Health University School of Medicine
-
- MURAKAMI Kazutaka
- Mizuno Clinic
-
- TOMITA Makoto
- Mizuno Clinic
-
- HASEGAWA Hiroshi
- Mizuno Clinic
-
- SHIKANO Masahiko
- Mizuno Clinic
-
- MIZUNO Masao
- Mizuno Clinic
-
- FUNAHASHI Naoki
- Toyota Memorial Hospital
-
- KAWASHIMA Shiro
- Showa Hospital
-
- SUGIYAMA Satoshi
- Department of Nephrology, Fujita Health University School of Medicine
Bibliographic Information
- Other Title
-
- 血液透析患者における鉄欠乏の指標としての網状赤血球ヘモグロビン量,低色素赤血球比率,血清トランスフェリンレセプター/血清鉄比の有用性
Search this article
Description
Reticulocyte hemoglobin content (CHr), percentage of hypochromic red blood cells (%HRC, level of serum transferrin receptor (sTfR), and STIR/serum iron ratio (sTfR/Fe) were measured in 132 hemodialysis patients. On univariate analysis, CHr was positively correlated with serum amyloid A (SAA) and negatively correlated with Kt/V. %HRC showed a positive correlation with the recombinant human erythropoietin (rHuEPO) dosage. The dependency of each iron-status index on 5 variables, SAA, sFt, TS, KtN, and dose of rHuEPO administered, was determined by stepwise multiple regression analysis. CHr was influenced only by TS, while %HRC, sTfR and sTfR/Fe were influenced by both logrHuEPO dosage and TS. Patients whose hemoglobin concentration increased by more than 1 g/dl following iron supplementa-tion were defined as Iron-Responders, and the remaining patients were defined as Iron-Nonresponders. Fifteen out of 20 patients responded to 10 consecutive intravenous administrations of 80 mg of saccharated ferric oxide at each dialysis session, while five did not. The baseline CHr was significantly lower in Iron-Responders than Iron-Nonresponders. The baseline %HRC, sTfR, and sTfR/Fe were significantly higher in Iron-Responders than Iron-Nonresponders. The baseline CHr, %HRC, and sTIR/Fe were correlated with the degree of change in Hb concentra-tion at 4 weeks of iron supplementation. The absolute change in CHr at 2 weeks of iron supplementation was positively correlated with the absolute change in Hb concentration over the first 4 weeks. Conclusion:(1) In assessing the iron metabolic status of dialysis patients, CHr, %HRC, and sTfR/ Fe were unique indices compared with the ordinary indices, particularly in diagnosing the functional iron deficiency state. (2) CHr was a valuable marker of iron deficiency anemia and could predict the degree of increase in Hb level following iron supplementation. (3) The %HRC and sTfR/Fe seemed to reflect both erythropoiesis induced by rHuEPO and the iron supply to erythropoietic cells.
Journal
-
- The Japanese Journal of Nephrology
-
The Japanese Journal of Nephrology 44 (5), 453-463, 2002
Japanese Society of Nephrology
- Tweet
Details 詳細情報について
-
- CRID
- 1390282679836010496
-
- NII Article ID
- 130004170588
- 10010593788
-
- NII Book ID
- AN10131749
-
- ISSN
- 18840728
- 03852385
-
- PubMed
- 12216478
-
- Text Lang
- ja
-
- Article Type
- journal article
-
- Data Source
-
- JaLC
- PubMed
- CiNii Articles
-
- Abstract License Flag
- Disallowed